Delving into the Latest Updates on Shenzhen Zhongke Ai Shen Pharmaceutical Co Ltd with Synapse

Overview

Tags

Neoplasms

Digestive System Disorders

Other Diseases

Biological products

Antibody

Oligonucleotide

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	6

Top 5 Drug Type	Count

Biological products	4
Antibody	2
Oligonucleotide	1
Biosimilar	1

Top 5 Target	Count

TNFAIP8L2(TNF alpha induced protein 8 like 2)	1
PD-1(Programmed cell death protein 1)	1
TRAIL(Tumor necrosis factor ligand superfamily member 10)	1
c-Rel(REL proto-oncogene, NF-kB subunit)	1

主要目的：评价注射用AS1501在中国健康受试者中单次静脉注射给药的耐受性和安全性，为后期临床研究推荐合理的给药方案；次要目的：（1）评价注射用AS1501在中国健康受试者中的药代动力学特征；（2）评价注射用AS1501在中国健康受试者中的免疫原性；探索性目的：初步探索注射用AS1501静脉注射给药前后血清中TRAIL表达水平的变化。

[Translation]

Main purpose: To evaluate the tolerability and safety of a single intravenous injection of AS1501 for injection in healthy Chinese subjects, and to recommend a reasonable dosing regimen for later clinical studies; Secondary purpose: (1) To evaluate the pharmacokinetic characteristics of AS1501 for injection in healthy Chinese subjects; (2) To evaluate the immunogenicity of AS1501 for injection in healthy Chinese subjects; Exploratory purpose: To preliminarily explore the changes in serum TRAIL expression levels before and after intravenous injection of AS1501 for injection.

Start Date27 Jun 2022

Sponsor / Collaborator

Shenzhen Zhongke Ai Shen Pharmaceutical Co Ltd

100 Clinical Results associated with Shenzhen Zhongke Ai Shen Pharmaceutical Co Ltd

Login to view more data

0 Patents (Medical) associated with Shenzhen Zhongke Ai Shen Pharmaceutical Co Ltd

Login to view more data

100 Deals associated with Shenzhen Zhongke Ai Shen Pharmaceutical Co Ltd

Login to view more data

100 Translational Medicine associated with Shenzhen Zhongke Ai Shen Pharmaceutical Co Ltd

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

1

4

Preclinical

Phase 1 Clinical

1

Phase 2 Clinical

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

AS-1601 ( PD-1 )	Neoplasms More	Phase 2
AS-1501 ( TRAIL )	liver function failure More	Phase 1
BS01(shenzhen zhongke amshen pharmaceutical)	Neoplasms More	Preclinical
AS1801	Inflammation More	Preclinical
AS1701 ( c-Rel )	Neoplasms More	Preclinical